Our journey began in 2018, with a challenge from Sponsors to apply the successful tactics which made the research facility directed by Dr. Stephen Harrison and Gail Hinkson the leading enroller of Metabolic dysfunction-associated steatohepatitis (MASH) studies around the world, all while consistently adhering to study timelines and quality. Gail and Dr. Harrison had found the secret sauce to tackling the challenges of MASH research. With an eye towards enabling other research sites to implement proven efficiencies, as well as mentoring PIs and other research staff on the intricacies of MASH protocols, Gail and Dr. Harrison created Summit, opening the doors with fifteen Network sites. Together, Summit and our initial group of sites embarked on using effective research strategies and logistical prowess to conduct quality research – managing high patient volumes without compromising data integrity.
Summit revolutionized MASH trial execution and continues to support research sites in achieving unparalleled success. We are led by a team of industry experts and fueled by a passion for advancing medical science. Our site Network has grown from the initial fifteen sites to well over 100 sites in 9 countries, and we continue to specialize in guiding research sites to new heights of efficiency and effectiveness.
At Summit, we understand that each research site is unique, with its own set of strengths and challenges. That’s why our approach is personalized, collaborative, and designed to meet the specific needs of each partner. By leveraging our extensive experience and industry insights, we empower sites to overcome obstacles, seize opportunities, and achieve their goals.
Join us on a journey of innovation, collaboration, and transformation. Together, we can define the future of therapeutically focused research and make a meaningful impact on the lives of patients worldwide. Welcome to Summit Clinical Research, where excellence meets innovation.
